Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1920 1
1922 1
1949 1
1973 2
1975 3
1976 2
1977 7
1978 2
1979 12
1980 8
1981 10
1982 9
1983 11
1984 11
1985 16
1986 7
1987 8
1988 9
1989 12
1990 16
1991 14
1992 14
1993 11
1994 18
1995 18
1996 20
1997 13
1998 18
1999 17
2000 14
2001 16
2002 14
2003 19
2004 19
2005 20
2006 19
2007 17
2008 23
2009 29
2010 27
2011 39
2012 29
2013 36
2014 36
2015 37
2016 50
2017 42
2018 34
2019 65
2020 64
2021 62
2022 61
2023 49
2024 30

Text availability

Article attribute

Article type

Publication date

Search Results

1,013 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment.
Muir CA, Clifton-Bligh RJ, Long GV, Scolyer RA, Lo SN, Carlino MS, Tsang VHM, Menzies AM. Muir CA, et al. J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3704-e3713. doi: 10.1210/clinem/dgab263. J Clin Endocrinol Metab. 2021. PMID: 33878162

Combination immunotherapy was strongly associated with development of overt thyrotoxicosis (odds ratio [OR] 10.8, 95% CI 4.51-25.6 vs CTLA-4 monotherapy; P < .001), as was female sex (OR 2.02, 95% CI 1.37-2.95; P < .001) and younger age (OR 0.83 per 10 years,

…
Combination immunotherapy was strongly associated with development of overt thyrotoxicosis (odds ratio [OR] 10.8, 95% CI 4.51-25.6 vs CTLA-4 …
Erect penile dimensions in a cohort of 778 Middle Eastern men: establishment of a nomogram.
Habous M, Tealab A, Williamson B, Binsaleh S, El Dawy S, Mahmoud S, Abdelwahab O, Nassar M, Mulhall JP, Veale D, Muir G. Habous M, et al. J Sex Med. 2015 Jun;12(6):1402-6. doi: 10.1111/jsm.12894. Epub 2015 Apr 22. J Sex Med. 2015. PMID: 25904106 Free article.

A nomogram was constructed and statistical analysis performed, demonstrating a weak negative correlation between BMI and erect penile length measured from the suprapubic skin (r = -0.283, P < 0.000) but not from bone to tip, and a weak negative correlation between age a

…
A nomogram was constructed and statistical analysis performed, demonstrating a weak negative correlation between BMI and erect penile length …
Commentary on "identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array." Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock SJ, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle AB, Clements JA, Teixeira MR, Dicks E, Lee A, Dunning AM, Baynes C, Conroy D, Maranian MJ, Ahmed S, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As NJ, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatananon A, Cox A, Southey MC, Hopper JL, English DR, Aly M, Adolfsson J, Xu J, Zheng SL, Yeager M, Kaaks R, Diver WR, Gaudet MM, Stern MC, Corral R, Joshi AD, Shahabi A, Wahlfors T, Tammela TL, Auvinen A, Virtamo J, Klarskov P, Nordestgaard BG, Roder MA, Nielsen SF, Bojesen SE, Siddiq A, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Blot WJ, Zheng W, Cai Q, McDonnell SK, Rinckleb AE, Drake B, Colditz G, Wokolorczyk D, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Sellers TA, Lin HY, Slavov C, Mitev V, Lose F, Srinivasan S, Maia S, Paulo P, Lange E, Cooney KA, Antoniou AC, Vincent D, Bacot F, Tessier DC; COGS-Cancer Research UK GWAS-ELLIPSE (part of GAME-ON) Initiative; Australian Prostate Cancer Bioresource; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT (Prostate testing for cancer and Treatment) Study.
Olumi AF. Olumi AF. Urol Oncol. 2014 Feb;32(2):211. doi: 10.1016/j.urolonc.2013.08.019. Urol Oncol. 2014. PMID: 24445293
Twenty-three new prostate cancer susceptibility loci were identified at genome-wide significance (P<510(-8)). More than 70 prostate cancer susceptibility loci, explaining ~30% of the familial risk for this disease, have now been identified. ...
Twenty-three new prostate cancer susceptibility loci were identified at genome-wide significance (P<510(-8)). More than 70 prostat …
Commentary on "A large-scale analysis of genetic variants within putative miRNA binding sites in prostate cancer." Stegeman S, Amankwah E, Klein K, O'Mara TA, Kim D, Lin HY, Permuth-Wey J, Sellers TA, Srinivasan S, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pharoah P, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Kaneva R, Teixeira MR, PRACTICAL Consortium, Australian Prostate Cancer BioResource, Spurdle AB, Clements JA, Park JY, Batra J, University of Washington-Urology, Seattle, WA. Cancer Discov 2015; 5(4):368-79.
Lin D. Lin D. Urol Oncol. 2016 Nov;34(11):522-523. doi: 10.1016/j.urolonc.2016.02.008. Urol Oncol. 2016. PMID: 27814883 No abstract available.
Activated Coagulation FXII: A Unique Target for In Vivo Molecular Imaging.
Walsh APG, Yu E, McFadyen JD, Bongcaron V, Moon MJ, Huang A, Arthur JF, Muir IL, Rayzman V, Panousis C, Wang X, Peter K. Walsh APG, et al. Arterioscler Thromb Vasc Biol. 2023 Jun;43(6):1031-1040. doi: 10.1161/ATVBAHA.122.318883. Epub 2023 Apr 20. Arterioscler Thromb Vasc Biol. 2023. PMID: 37078286
RESULTS: We demonstrated imaging of carotid thrombosis by fluorescence emission computed tomography/computed tomography and measured a significant fold increase in signal between healthy and control vessels from mice injected with 3F7-NIR compared with mice injected with nontarge …
RESULTS: We demonstrated imaging of carotid thrombosis by fluorescence emission computed tomography/computed tomography and measured a signi …
Micronodular pneumocyte hyperplasia.
Muir TE, Leslie KO, Popper H, Kitaichi M, Gagné E, Emelin JK, Vinters HV, Colby TV. Muir TE, et al. Am J Surg Pathol. 1998 Apr;22(4):465-72. doi: 10.1097/00000478-199804000-00012. Am J Surg Pathol. 1998. PMID: 9537475
Esophageal remodeling in eosinophilic esophagitis: Relationships to luminal captured biomarkers of inflammation and periostin.
Muir AB, Ackerman SJ, Pan Z, Benitez A, Burger C, Spergel JM, Furuta GT, Rothman J, Wilkins BJ, Arnold MA, Dolinsky L, Grozdanovic M, Menard-Katcher C. Muir AB, et al. J Allergy Clin Immunol. 2022 Sep;150(3):649-656.e5. doi: 10.1016/j.jaci.2022.03.022. Epub 2022 Apr 8. J Allergy Clin Immunol. 2022. PMID: 35405206 Free PMC article.

EST-captured eotaxin-3, major basic protein 1, EDN, eosinophil peroxidase, and Charcot-Leyden crystal protein/galectin-10 showed significant correlations with peak eosinophils per high-power field (rho 0.53-0.68, P < .001). Luminal proteins positively correlated with en

…
EST-captured eotaxin-3, major basic protein 1, EDN, eosinophil peroxidase, and Charcot-Leyden crystal protein/galectin-10 showed significant …
Locust epidemic in Africa raises environmental concerns.
Dastnai S, Dietz R, Sonne C. Dastnai S, et al. Chemosphere. 2021 May;270:129454. doi: 10.1016/j.chemosphere.2020.129454. Epub 2020 Dec 28. Chemosphere. 2021. PMID: 33401073 No abstract available.
Hereditary colorectal cancer: risk assessment and management.
Hampel H, Peltomaki P. Hampel H, et al. Clin Genet. 2000 Aug;58(2):89-97. doi: 10.1034/j.1399-0004.2000.580201.x. Clin Genet. 2000. PMID: 11005140 Review.
There are at least nine major cancer susceptibility syndromes that infer an increased risk for colorectal cancer and/or colorectal polyposis; hereditary nonpolyposis colorectal cancer syndrome, Muir-Torre syndrome, Turcot syndrome, the I1307K polymorphism of the APC gene, …
There are at least nine major cancer susceptibility syndromes that infer an increased risk for colorectal cancer and/or colorectal polyposis …
1,013 results